Oncology Frontier: 2023 ESMO launched the info of section III trial of induction chemotherapy adopted by chemoradiation in contrast with chemoradiation alone in domestically superior cervical cancer（LBA8）. Oncology Frontier: The 2023 ESMO has launched the outcomes of quite a lot of gynecol...
